Ken Griffin’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$122M Sell
258,709
-82,751
-24% -$41.7M 0.02% 690
2025
Q4
$159M Buy
341,460
+263,650
+339% +$122M 0.02% 595
2025
Q3
$33.2M Buy
+77,810
New +$30.2M 0.01% 1772
2025
Q1
Sell
-156,910
Closed -$50.5M 14914
2024
Q4
$47.1M Buy
156,910
+121,763
+346% +$42.6M 0.01% 1320
2024
Q3
$14.3M Sell
35,147
-15,490
-31% -$5.67M ﹤0.01% 2434
2024
Q2
$16.3M Sell
50,637
-115,446
-70% -$37.5M ﹤0.01% 2215
2024
Q1
$55.4M Buy
166,083
+76,453
+85% +$23.4M 0.01% 1131
2023
Q4
$24.3M Sell
89,630
-380,913
-81% -$94.1M ﹤0.01% 1820
2023
Q3
$116M Buy
470,543
+61,107
+15% +$16.7M 0.02% 555
2023
Q2
$124M Sell
409,436
-283,487
-41% -$78.8M 0.03% 503
2023
Q1
$183M Sell
692,923
-437,382
-39% -$111M 0.04% 360
2022
Q4
$271M Sell
1,130,305
-357,368
-24% -$80M 0.06% 233
2022
Q3
$273M Buy
1,487,673
+1,147,493
+337% +$229M 0.06% 206
2022
Q2
$57.2M Buy
340,180
+193,369
+132% +$41.5M 0.01% 914
2022
Q1
$36.8M Sell
146,811
-142,718
-49% -$35.8M 0.01% 1360
2021
Q4
$74.4M Sell
289,529
-427,374
-60% -$105M 0.02% 874
2021
Q3
$174M Buy
+716,903
New +$175M 0.04% 398
2021
Q2
Sell
-202,595
Closed -$41.3M 13973
2021
Q1
$38.2M Sell
202,595
-1,032,916
-84% -$182M 0.01% 1276
2020
Q4
$203M Buy
1,235,511
+1,134,505
+1,123% +$166M 0.05% 254
2020
Q3
$12.6M Sell
101,006
-266,113
-72% -$32.9M ﹤0.01% 2017
2020
Q2
$35.6M Sell
367,119
-1,022,513
-74% -$106M 0.01% 1020
2020
Q1
$125M Sell
1,389,632
-758,075
-35% -$98.1M 0.06% 260
2019
Q4
$317M Buy
2,147,707
+1,104,608
+106% +$148M 0.14% 95
2019
Q3
$126M Sell
1,043,099
-113,689
-10% -$14.7M 0.06% 299
2019
Q2
$156M Buy
1,156,788
+312,230
+37% +$39.5M 0.07% 228
2019
Q1
$110M Buy
844,558
+553,192
+190% +$74.3M 0.05% 324
2018
Q4
$36.3M Sell
291,366
-752,421
-72% -$101M 0.02% 804
2018
Q3
$145M Buy
1,043,787
+1,039,107
+22,203% +$129M 0.06% 275
2018
Q2
$480K Sell
4,680
-310,705
-99% -$31.4M ﹤0.01% 6436
2018
Q1
$30.6M Buy
315,385
+160,791
+104% +$15.6M 0.02% 840
2017
Q4
$13.6M Buy
+154,594
New +$12.4M 0.01% 1431
2017
Q2
Sell
-33,489
Closed -$2.83M 7697
2017
Q1
$2.98M Buy
33,489
+5,301
+19% +$442K ﹤0.01% 2592
2016
Q4
$2.09M Sell
28,188
-390,574
-93% -$29.3M ﹤0.01% 2906
2016
Q3
$31.7M Buy
418,762
+383,028
+1,072% +$29.3M 0.03% 615
2016
Q2
$2.75M Buy
35,734
+7,704
+27% +$608K ﹤0.01% 2403
2016
Q1
$2.19M Sell
28,030
-23,126
-45% -$1.61M ﹤0.01% 2547
2015
Q4
$3.46M Sell
51,156
-209,314
-80% -$14.6M ﹤0.01% 2166
2015
Q3
$20.1M Buy
260,470
+136,038
+109% +$12M 0.02% 898
2015
Q2
$11.3M Sell
124,432
-185,642
-60% -$14.9M 0.01% 1384
2015
Q1
$23.3M Sell
310,074
-293,142
-49% -$21.1M 0.02% 897
2014
Q4
$44.3M Sell
603,216
-842,202
-58% -$59.2M 0.04% 529
2014
Q3
$102M Buy
1,445,418
+149,160
+12% +$9.86M 0.11% 188
2014
Q2
$73.1M Sell
1,296,258
-123,364
-9% -$6.51M 0.08% 257
2014
Q1
$74.5M Buy
1,419,622
+1,341,868
+1,726% +$66.8M 0.09% 241
2013
Q4
$3.71M Sell
77,754
-1,442,424
-95% -$66.7M ﹤0.01% 1938
2013
Q3
$65M Buy
1,520,178
+587,360
+63% +$23M 0.1% 214
2013
Q2
$33.6M Buy
+932,818
New +$36.1M 0.06% 396

Other funds holding HCA

Ken Griffin's HCA Position: Q1 2026 in Review

Ken Griffin reduced its HCA Healthcare (HCA) stake by 24% in Q1 2026, selling an estimated $41.7M and leaving 258,709 shares worth $122M. The position accounts for 0.02% of the portfolio, ranked #690.

Ken Griffin first reported a position in HCA in Q2 2013 and has held it in 47 quarters since. The position peaked at $317M in Q4 2019. 1,419 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Ken Griffin held 258,709 shares of HCA Healthcare worth $122M as of Q1 2026.
  • Ken Griffin sold 82,751 HCA Healthcare shares in Q1 2026, an estimated $41.7M.
  • HCA Healthcare made up 0.02% of Ken Griffin's portfolio in Q1 2026, its #690 holding.
  • Ken Griffin first reported a position in HCA Healthcare in Q2 2013 and has held it in 47 quarters since.
  • Ken Griffin's HCA Healthcare position peaked at $317M in Q4 2019.
  • 1,419 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.